We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

30 hedge funds and large institutions have $4.42M invested in LYRA THERAPEUTICS INC in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more capital invested

Capital invested by funds: $3.23M → $4.42M (+$1.19M)

36.5% more ownership

Funds ownership: 0.78%37.28% (+36%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

47% less funds holding

Funds holding: 5730 (-27)

77% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 35

Holders
30
Holders Change
-27
Holders Change %
-47.37%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
8
Increased
8
Reduced
10
Closed
35
Calls
Puts
Net Calls
Net Calls Change

LYRA Hedge Fund Activity: Q2 2025 in Review

30 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q2 2025, worth a combined $4.42M — up 37% from $3.23M a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of LYRA and 8 opened new positions — a net loss of 27 holders — while 10 trimmed existing stakes and 8 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.04M. The largest seller was BlackRock, cutting an estimated $487K.

  • 30 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q2 2025, down from 57 in Q1 2025.
  • Funds reported $4.42M of LYRA THERAPEUTICS INC stock for Q2 2025, up 37% quarter-over-quarter.
  • 8 funds opened new LYRA THERAPEUTICS INC positions in Q2 2025 and 35 closed out, a net change of -27 holders.
  • The largest LYRA THERAPEUTICS INC buyer in Q2 2025 was Sabby Management, an estimated $1.04M added.
  • The largest LYRA THERAPEUTICS INC seller in Q2 2025 was BlackRock, an estimated $487K sold.

Based on aggregated 13F filings for Q2 2025.